Allogenic stem cell transplantation for children with advanced MDS:: results from the EWOG-MDS study group employing a pre-transplant preparative regimen with busulfan, cyclophosphamide and melphalan

被引：0
|
作者：
Niemeyer, CM
Zecca, M
Korthoff, E
Duffner, U
Zintl, F
Ebell, W
Stary, J
Dillo, D
Bader, P
Peters, C
Schmugge, M
Sedlacek, P
van Heuvel, M
Bergsträsser, E
Trebo, M
Nölke, P
Locateffl, F
机构：
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 44 条
  • [31] Prognostic Pre-Transplant Factors in Myelodysplastic Syndromes Primarily Treated by Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study on Behalf of the MDS Subcommittee of the Chronic Leukaemia Working Party of the EBMT
    Cremers, Eline
    van Biezen, Anja
    de Wreede, Liesbeth C.
    Scholten, Marijke
    Vitek, Antonin
    Finke, Juergen
    Platzbecker, Uwe
    Beelen, Dietrich
    Schwerdtfeger, Rainer
    Volin, Liisa
    Harhalakis, Nikolaos
    Schattenberg, Anton
    Nagler, Arnon
    de Witte, Theo
    Kroeger, Nicolaus
    BLOOD, 2011, 118 (21) : 1298 - 1299
  • [32] Prospective analysis of prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by allogeneic haematopoietic stem cell transplantation: a study on behalf of the MDS subcommittee of the Chronic Malignancies Working Party of the EBM
    Cremers, E.
    de Wreede, L.
    Knoedler, E.
    Finke, J.
    Ditschkowski, M.
    Robin, M.
    Maertens, J.
    Brinch, L.
    Volin, L.
    Martino, R.
    Kobbe, G.
    de Witte, T.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S18 - S18
  • [33] Hematopoietic stem cell transplantation (HSCT) with a conditioning regimen of busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): A phase I study of the Pediatric Blood and Marrow Transplant Consortium
    Sandler, ES
    Hagg, R
    Coppes, MJ
    Mustafa, MM
    Gamis, A
    Kamani, N
    Wall, D
    MEDICAL AND PEDIATRIC ONCOLOGY, 2000, 35 (04): : 403 - 409
  • [34] Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMT
    Gorin, Norbert Claude
    Labopin, Myriam
    Blaise, Didier
    Dumas, Pierre-Yves
    Pabst, Thomas
    Trisolini, Silvia Maria
    Arcese, William
    Houhou, Mohamed
    Mohty, Mohamad
    Nagler, Arnon
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 859 - 866
  • [35] Thiotepa-Busulfan-Fludarabine in Comparison to Busulfan-Cyclophosphamide As Myeloablative Conditioning Regimen Pre Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
    Saraceni, Francesco
    Beohou, Eric
    Labopin, Myriam
    Arcese, William
    Bonifazi, Francesca
    Stepensky, Polina
    Aljurf, Mahmoud
    Bruno, Benedetto
    Pioltelli, Pietro
    Passweg, Jakob R.
    Socie, Gerard
    Santarone, Stella
    Yakoub-Agha, Ibrahim
    Savani, Bipin N.
    Mohty, Mohamad
    Nagler, Arnon
    BLOOD, 2017, 130
  • [36] Low transplant related mortality following allogeneic peripheral stem cell transplantation with reduced-intensity conditioning regimen in myelodysplastic syndrome and acute myeloid leukaemia from MDS:: a prospective study from GITMO
    Alessandrino, EP
    La Nasa, G
    Malcovati, L
    De Fabritiis, P
    Bregni, M
    Mazza, P
    Di Bartolomeo, P
    Locasciulli, A
    Scimè, R
    Mordini, N
    Olivieri, A
    Deliliers, GL
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S34 - S34
  • [37] Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
    Jaime Sanz
    Myriam Labopin
    Thomas Pabst
    Jurjen Versluis
    Gwendolyn Van Gorkom
    Ellen Meijer
    Tobias Gedde-Dahl
    Juan Montoro
    William Arcese
    Jose Antonio Pérez-Simón
    Nicolaas Schaap
    Johan Maertens
    Radovan Vrhovac
    Francesco Lanza
    Norbert Claude Gorin
    Mohamad Mohty
    Fabio Ciceri
    Bone Marrow Transplantation, 2023, 58 : 1197 - 1202
  • [38] Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
    Sanz, Jaime
    Labopin, Myriam
    Pabst, Thomas
    Versluis, Jurjen
    Van Gorkom, Gwendolyn
    Meijer, Ellen
    Gedde-Dahl, Tobias
    Montoro, Juan
    Arcese, William
    Perez-Simon, Jose Antonio
    Schaap, Nicolaas
    Maertens, Johan
    Vrhovac, Radovan
    Lanza, Francesco
    Gorin, Norbert Claude
    Mohty, Mohamad
    Ciceri, Fabio
    BONE MARROW TRANSPLANTATION, 2023, 58 (11) : 1197 - 1202
  • [39] Busulfan and melphalan as consolidation therapy with autologous peripheral blood stem cell transplantation following Children's Oncology Group (COG) induction platform for high-risk neuroblastoma: Early results from a single institution
    Soni, Sandeep
    Pai, Vinita
    Gross, Thomas G.
    Ranalli, Mark
    PEDIATRIC TRANSPLANTATION, 2014, 18 (02) : 217 - 220
  • [40] Allogeneic stem cell transplantation using busulfan, cyclophosphamide, and melphalan for children with acute myeloid leukaemia in second complete remission: retrospective interphase analysis on behalf of the German AML-BFM study data from the paediatric BFM
    Beier, R.
    Albert, M. H.
    Bader, P.
    Borkhardt, A.
    Creutzig, U.
    Eyrich, M.
    Gruhn, B.
    Greil, J.
    Handgretinger, R.
    Holter, W.
    Kremens, B.
    Lang, P.
    Mueller, I.
    Mauz-Koerholz, C.
    Meisel, R.
    Peters, C.
    Reinhardt, R.
    Roessig, C.
    Sedlacek, P.
    Schulz, A.
    Schuster, F.
    Schrauder, A.
    Strahm, B.
    Sykoa, K. W.
    Woessmann, W.
    Zimmermann, M.
    Sauer, M. G.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S37 - S38
12345